Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Portrait de Freda C. Lewis-Hall
EtÓ : 65
Patrimonio pubblico : 2 988 763 USD
Principali societÓ : Exact Sciences Corporation - 1Life Healthcare, Inc. - SpringWorks Therapeutics, Inc.
Riassunto 
Freda C. Lewis-Hall is Director-Drug Discovery, Development & Translation at Institute of Medicine and Chairman-Cures Acceleration Network Review Board at National Center for Advancing Translational Sciences and on the board of 10 other companies.

She previously held the position of Senior VP-US Pharmaceuticals & Medical Affairs at Bristol Myers Squibb Co., Chief Patient Officer & Executive Vice President at Pfizer Inc. and VP-Product Development, Research & Development at Pharmacia Corp. (a subsidiary of Pfizer Inc.), Chief Medical Officer & EVP-Medicines Development at Vertex Pharmaceuticals, Inc., Principal at Eli Lilly & Co., Principal at National Institute of Mental Health, Chairman of National Minority Supplier Development Council, Inc. and Professor at Howard University College of Medicine.

Freda C. Lewis-Hall received an undergraduate degree from The Johns Hopkins University and a doctorate from Howard University College of Medicine.


Posti e reponsabilitÓ di Freda C. Lewis-Hall 
NomeTitolo Da
Exact Sciences Corporation
(Biotecnologia)
Independent Director 2020
1Life Healthcare, Inc.
(Prestatari di assistenza sanitaria)
Independent Director 2019
SpringWorks Therapeutics, Inc.
(Biotecnologia)
Independent Director 2017
American Heart Association, Inc. Director -
Save The Children Federation, Inc. Trustee -
FasterCures Director -
Foundation for the National Institutes of Health, Inc. Director -
American Psychiatric Foundation Director -
Harvard Medical School Director -
SpringWorks Therapeutics LLC Director -
Institute of Medicine Director-Drug Discovery, Development & Translation 2015
National Center for Advancing Translational Sciences Chairman-Cures Acceleration Network Review Board -


Participazioni di Freda C. Lewis-Hall 
NomeAzioni%Valorizzazione
SpringWorks Therapeutics, Inc. (SWTX)
(Biotecnologia)
25 2270,051%1 894 548 USD
Exact Sciences Corporation (EXAS)
(Biotecnologia)
10 4830,0061%1 094 216 USD
1Life Healthcare, Inc. (ONEM)
(Prestatari di assistenza sanitaria)
00,0000%0 USD


Freda C. Lewis-Hall: network personale 
Le notizie pi¨ lette 
15/09BRAD SMITH: Microsoft annuncia il riacquisto di azioni fino a 60 miliardi di dollari e aumenta il dividendo
MR
13/09MARTIN SORRELL: S4 Capital di Sorrell alza le prospettive di profitto al 40%
MR
14/09STEPHEN SCHERR: Goldman Sachs nomina Coleman come nuovo CFO, sostituendo Scherr
MR
17/09LEONARDO DEL VECCHIO: Generali, Caltagirone e Del Vecchio cercano alleati, non vogliono Opa
RE
08/09MICHAEL O'LEARY: Ryanair, aeroporti britannici in difficoltà a Natale - O'Leary
RE
15/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone aumenta quota di ulteriore 0,11%, sale sopra 6%
RE
09/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone arrotonda quota a 6,1%
RE
10:39GIUSEPPE CASTAGNA: Banco Bpm, non ci sono presupposti per consolidamento - Castagna a Corriere
RE
14/09VINCENT BOLLORÉ: Bolloré avrà quota Universal da 5,9 mld euro dopo quotazione
RE
Pi¨ notizie


© 2021 People and Ownership :   
Freda C. Lewis-Hall : connessioni